SEP 01, 2020 7:21 AM PDT

Scalp Implants Monitor Epileptic Seizures

WRITTEN BY: Tara Fernandez

Neuroscientists have developed devices that, when implanted under the scalp of individuals living with epilepsy, can monitor and record seizures over time to better manage the condition clinically. Presently, physicians rely heavily on patient self-reporting in the form of “seizure diaries” in order to map the frequency and triggers of epileptic episodes in order to tailor their medication. This is highly subjective, considering that over half of seizures are not known to patients.

This new wave of brain monitoring technologies use subscalp electroencephalography, or EEG, and are regarded by neuroscientists as a minimally invasive and reliable alternative to self-reporting, as reported in a recent article in Epilepsia. Co-author Maxime Baud from Bern University Hospital said, “Our current epilepsy treatment plans are primarily based on short-term brain activity data from EEG caps during a hospital visit. Epileptic seizures can occur months apart and come in cycles, so we need ways to, continuously and accurately, monitor brain activity in the home environment.”

One of the innovations highlighted in the article is the Epios™ system, which can be customized to the patient, with a series of sensing electrodes linked to a tiny implant that is inserted just beneath the scalp. The electrodes pick up brain activity signals and transmit them wirelessly to an external receiver, worn behind the patient’s ear. The device also measures the heart rate, patient movements, and surrounding audio, uploading all this data to secure and centralized cloud storage.

George Kouvas from the Wyss Center and co-author of the article said: “In parallel to the recording devices, we are constantly optimizing our high performance analytics software with algorithms that could help clinicians draw meaningful conclusions from the vast amount of data recorded by these long-term systems.” 

“We are already working towards adapting these new technologies to help patients with other brain disorders manage their daily life, such as with tinnitus and stroke,” Kouvas added.

 

 

Sources: Epilepsia, Technology Networks.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUL 11, 2020
Cardiology
Predicting a Heart Attack's Prognosis with Biomarkers
JUL 11, 2020
Predicting a Heart Attack's Prognosis with Biomarkers
Biomarker studies have taken the diagnostic field by storm these past few decades. Many diseases will have unique g ...
JUL 13, 2020
Cancer
Workers in Transportation Might be More at Risk for Cancer
JUL 13, 2020
Workers in Transportation Might be More at Risk for Cancer
Road transportation workers are essential employees in any country. They represent truck, bus, taxi, and other such driv ...
JUL 14, 2020
Clinical & Molecular DX
The Smell of Rotten Fish Could Help Predict the Recovery of Unresponsive Patients
JUL 14, 2020
The Smell of Rotten Fish Could Help Predict the Recovery of Unresponsive Patients
A study published in the journal Nature provides new evidence supporting an unconventional test to map recovery paths of ...
JUL 27, 2020
Cancer
Identifying Tumor Cells in the Blood with Artificial Intelligence
JUL 27, 2020
Identifying Tumor Cells in the Blood with Artificial Intelligence
Cancer diagnostics is an area of keen interest in the fight against cancer. Cancer often slips by routine checkups and v ...
AUG 20, 2020
Cardiology
A New Test to Discern Kawasaki Disease from Sepsis
AUG 20, 2020
A New Test to Discern Kawasaki Disease from Sepsis
Kawasaki disease is a rare cardiovascular disease affecting children under the age of five. If untreated, there is a cha ...
SEP 21, 2020
Cancer
The Protein ETV1 May Act as a Biomarker for Gastrointestinal Cancer
SEP 21, 2020
The Protein ETV1 May Act as a Biomarker for Gastrointestinal Cancer
Cancer is an incredibly diverse disease. It has many types and even sub-types, with a vast range of characteristics. Som ...
Loading Comments...